Free press releases distribution network?

Agency / Source: Xhale, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Assurance Biosense to Unveil Next-Generation Alar Sensor at the IARS Meeting - New device surmounts shortcomings of existing fingertip sensors -
Assurance Biosense to Unveil Next-Generation Alar Sensor at the IARS Meeting


PRZOOM - /newswire/ - Glastonbury, CT, United States, 2013/05/03 - New device surmounts shortcomings of existing fingertip sensors -

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Assurance Biosense, a subsidiary of Xhale, Inc., today announced that it will unveil its next-generation Assurance® Alar Sensor at the International Anesthesia Research Society (IARS) meeting in San Diego May 4-7, 2013. The IARS meeting is attended by more than 1,000 of the world’s leading anesthesia educators and investigators and focuses on the latest advances in research and the best practices in anesthesia critical care.

The Assurance Alar Sensor, which recently received U.S. Food and Drug Administration (FDA) 510(k) clearance, monitors oxygen saturation of arterial hemoglobin (SpO2) and pulse rate from the nasal ala of adult and pediatric patients. The sensor measures blood flow at the nasal ala, the fleshy lateral part of the nares, and research has shown it to be more accurate and reliable than existing pulse oximetry devices using clip-on fingertip monitors. Moving the sensor from the hands to the ala improves patient comfort and allows patients greater freedom of movement.

The nasal ala is a superior measurement point because it is rich in vasculature and fed by both the external and internal carotid arteries, the same central blood supply as the brain. This multi-directional arterial supply provides strong, reliable signals that are highly responsive to change. This measurement site, unlike the fingertips, is unaffected by reductions in peripheral perfusion common in patients with cardio-respiratory comorbidities who are undergoing trauma-related shock, those receiving vasoactive drugs and those who are just cold as they are transported into the operating room for a procedure.

Additionally, the Alar Sensor’s design and placement makes it immune to interference from ambient light, including sunlight, a common problem with fingertip sensors. Assurance Alar Sensors are compatible with a variety of monitors currently in the market, including all that use Nellcor OxiSmart II sensors.

“The Assurance Alar Sensor is the next generation pulse oximeter sensor,” said Richard J. Melker, M.D., Ph.D., CTO (Professor of Anesthesiology and Pediatrics at the University of Florida College of Medicine and co-founder of Xhale). “We believe that participants at the IARS meeting will appreciate its superiority over existing technology.”

The Assurance Alar Sensor improves patient safety because it detects signals even at low oxygen saturation, senses changes in oxygenation sooner and reduces false alarms that commonly occur with existing pulse oximetry devices using clip-on fingertip monitors to measure a patient’s blood flow.

Pulse oximeters have become ubiquitous in hospitals for monitoring virtually all patients because they can give clinicians an early warning of low arterial blood oxygen saturation levels, known as hypoxemia. Early detection is critical because hypoxemia can result in brain damage or death in a matter of minutes.

However, conventional fingertip-measured pulse oximetry can lead to false readings that compromise the quality of patient care. Studies have found that more than 70 percent of the conventional pulse oximetry alarms outside the operating room are false. In the operating room, studies show that in up to 9 percent of cases, conventional pulse oximeters fail to give any measurements due to low perfusion.

The Assurance Alar Sensor is designed for the continuous non-invasive monitoring of SpO2 from the nasal ala of adult and pediatric patients (weighing >30kg). The sensor fits to the nasal ala without adhesives and is easily checked or repositioned by the clinician as necessary, allowing it to remain on the patient for the full length of stay. Studies at the Hypoxia Research Laboratory at the University of California San Francisco demonstrate the Assurance Alar Sensor’s consistent accuracy throughout the ranges of 70-80 percent, 80-90 percent and 90-100 percent oxygen saturation.

“IARS is an ideal meeting to first show our Assurance Alar Sensor,” said Andrew E. Kersey, President of Assurance Biosense. “Pulse oximetry is widely considered the fifth vital sign and is a critical component of assessing a patient’s condition. We believe this sensor offers a unique solution to improve upon the measurement of pulse oximetry, providing faster and more reliable detection of oxygen saturation changes than conventional sensors.”

About Assurance Biosense

Assurance Biosense (, a wholly owned subsidiary of Xhale, Inc., is committed to providing clinicians with easy-to-use, cost-effective diagnostic solutions that improve patient safety and reduce false alarms. Its Assurance® line of PPG/oximetry sensors monitor central blood through are uniquely designed to monitor by placement on the nasal ala, a region rich in vasculature, fed by the external and internal carotid arteries which also supply the brain. The unique physiology of the site provides a much stronger signal than that from a fingertip or extremity, delivering more robust pulse oximetry signals. Measurement from this site will enable monitoring a range of critical physiologic parameters which cannot be monitored via conventional pulse oximetry.

About Xhale

Xhale, Inc. (, is a medical technology innovator, developing products that transform healthcare and save lives. The company is a world leader in the use of sensors that analyze vapor and exhaled breath and is focused on novel patient-centric monitoring solutions. Its two current product lines include SMART®, the world’s only definitive medication adherence monitoring system, and Assurance®, a single-point-of-contact sensor that monitors multiple patient parameters more comfortably and conveniently than finger-based pulse oximetry with fewer false alarms.

(Note: Certain applications described above have not been reviewed by the FDA, and are therefore labeled for investigational use only.)

For more information, please visit the website or contact Investor Relations .

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Agency / Source: Xhale, Inc.


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker


Distribution / Indexing: [+]

# # #
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!

Assurance Biosense to Unveil Next-Generation Alar Sensor at the IARS Meeting

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Contact: Richard Allen - 
352-371-8488 info[.] / ir[.]
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Xhale, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Press Releases From Xhale, Inc. / Company Profile

Read Medical Services/Equipment Most Recent Related Press Releases:

Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps
Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing
GE Healthcare’s Biosafe Announces Sefia Platform to Address Multiple Steps in Cell Therapy Production Process

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...


Visit  Intrinsic Executive Search Ltd

Visit  MagLar, Inc.

Visit  Demyk Lightmod Products, Inc.

  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today